Advanced Search
Submit Manuscript Volume 30, No 6, Jun 2020
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 30 Issue 6, June 2020: 541-543 |
Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient
Xiao-Hong Yao1,2,† , Zhi-Cheng He1,2,† , Ting-Yuan Li3,† , Hua-Rong Zhang1,2,† , Yan Wang1,2,† , Huaming Mou4 , Qiaonan Guo5 , Shi-Cang Yu1,2,6 , Yanqing Ding7 , Xindong Liu1,2,* , Yi-Fang Ping1,2,* , Xiu-Wu Bian1,2,*
1Institute of Pathology & Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China;Dear Editor,
SARS-CoV-2, a novel coronavirus and causing COVID-19, has given rise to a worldwide pandemic.1,2 So far, tens of thousands of COVID-19 patients have been clinically cured and discharged, but multiple COVID-19 cases showed SARS-CoV-2 positive again in discharged patients,3 which raises an attention for the discharged patients. Also, there is an urgent need to understand the pathogenesis of SARS-CoV-2 infection. Here, we conducted postmortem pathologic study in a ready-for-discharge COVID-19 patient who succumbed to sudden cardiovascular accident. Pathological examination revealed SARS-CoV-2-viruses remaining in pneumocytes and virus-caused pathological changes in the lungs. Our study provided new insights into SARS-CoV-2 pathogenesis and might facilitate the improvement of clinical guideline for virus containment and disease management.
https://doi.org/10.1038/s41422-020-0318-5